Literature DB >> 12208733

Demonstration of Epstein-Barr virus in carcinomas of various sites.

Saul Grinstein1, Maria Victoria Preciado, Paolo Gattuso, Paola A Chabay, William H Warren, Elena De Matteo, Victor E Gould.   

Abstract

EBV is an etiological agent in infectious mononucleosis, is implicated in some malignant lymphomas and lymphoepithelioma-like carcinomas, and has been sporadically reported in carcinomas of the breast, lung, and other sites. We studied immunohistochemically benign and malignant tumors of the breast, lung, colon, and prostate and found EBV in some carcinomas of those sites. Also, EBV reactions were noted in hyperplasias and dysplasias, e.g., breast carcinomas in situ and prostatic intraepithelial neoplasia. Benign tumor counterparts were negative. PCR analysis of selected cases confirmed the presence of EBV. Our results suggest that EBV is not restricted to lymphoepithelioma-like carcinomas but may play an oncogenic role in frequent epithelial cancers and possibly also in hyperplasias and certain dysplasias preceding carcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208733

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Absence of Epstein-Barr virus EBER transcripts in male breast cancer.

Authors:  Ricardo Fonseca; Ana Raquel Tomás; Saudade André
Journal:  Virchows Arch       Date:  2005-05-31       Impact factor: 4.064

2.  cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis.

Authors:  Wei Yue; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Authors:  Melissa Milbrandt; Anke C Winter; Remington L Nevin; Ratna Pakpahan; Gary Bradwin; Angelo M De Marzo; Debra J Elliott; Charlotte A Gaydos; William B Isaacs; William G Nelson; Nader Rifai; Lori J Sokoll; Jonathan M Zenilman; Elizabeth A Platz; Siobhan Sutcliffe
Journal:  Prostate       Date:  2017-07-12       Impact factor: 4.104

4.  Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women.

Authors:  Maryam Kadivar; Ahmad Monabati; Azadeh Joulaee; Niloufar Hosseini
Journal:  Pathol Oncol Res       Date:  2011-01-06       Impact factor: 3.201

Review 5.  Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?

Authors:  Johannes Mischinger; Eva Comperat; Christian Schwentner; Arnulf Stenzl; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

6.  Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma.

Authors:  Julie L Ryan; Hongxin Fan; Sally L Glaser; Steven A Schichman; Nancy Raab-Traub; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

7.  Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.

Authors:  Deepti Joshi; Munira Quadri; Neha Gangane; Rajnish Joshi; Nitin Gangane
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

8.  Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma.

Authors:  Mario A Lorenzetti; Elena De Matteo; Hugo Gass; Paula Martinez Vazquez; Julia Lara; Pedro Gonzalez; María Victoria Preciado; Paola A Chabay
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

9.  Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo.

Authors:  Julie L Ryan; Richard J Jones; Sandra H Elmore; Shannon C Kenney; George Miller; Jane C Schroeder; Margaret L Gulley
Journal:  Intervirology       Date:  2009-04-07       Impact factor: 1.763

Review 10.  Synchronous adenocarcinoma and extranodal natural killer/T-cell lymphoma of the colon: a case report and literature review.

Authors:  Chih-En Tseng; Ta-Wen Shu; Chih-Wen Lin; Kai-Sheng Liao
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.